nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.0283	0.0399	CbGbCtD
Imipramine—ORM1—Saquinavir—acquired immunodeficiency syndrome	0.0273	0.0385	CbGbCtD
Imipramine—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0224	0.0315	CbGbCtD
Imipramine—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0217	0.0306	CbGbCtD
Imipramine—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0217	0.0305	CbGbCtD
Imipramine—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0196	0.0276	CbGbCtD
Imipramine—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0182	0.0256	CbGbCtD
Imipramine—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0171	0.0241	CbGbCtD
Imipramine—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0171	0.0241	CbGbCtD
Imipramine—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0168	0.0236	CbGbCtD
Imipramine—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0163	0.0229	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0163	0.0229	CbGbCtD
Imipramine—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0155	0.0218	CbGbCtD
Imipramine—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0146	0.0205	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.014	0.0198	CbGbCtD
Imipramine—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.014	0.0198	CbGbCtD
Imipramine—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0136	0.0192	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0136	0.0192	CbGbCtD
Imipramine—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.013	0.0183	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0123	0.0173	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0123	0.0173	CbGbCtD
Imipramine—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0123	0.0173	CbGbCtD
Imipramine—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0123	0.0173	CbGbCtD
Imipramine—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0119	0.0167	CbGbCtD
Imipramine—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0117	0.0165	CbGbCtD
Imipramine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0116	0.0163	CbGbCtD
Imipramine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0109	0.0153	CbGbCtD
Imipramine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0107	0.015	CbGbCtD
Imipramine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.01	0.0141	CbGbCtD
Imipramine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.01	0.0141	CbGbCtD
Imipramine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00983	0.0138	CbGbCtD
Imipramine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00983	0.0138	CbGbCtD
Imipramine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00907	0.0128	CbGbCtD
Imipramine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00879	0.0124	CbGbCtD
Imipramine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00877	0.0124	CbGbCtD
Imipramine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00849	0.012	CbGbCtD
Imipramine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00827	0.0116	CbGbCtD
Imipramine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00827	0.0116	CbGbCtD
Imipramine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00824	0.0116	CbGbCtD
Imipramine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00793	0.0112	CbGbCtD
Imipramine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0076	0.0107	CbGbCtD
Imipramine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00748	0.0105	CbGbCtD
Imipramine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00748	0.0105	CbGbCtD
Imipramine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00745	0.0105	CbGbCtD
Imipramine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00745	0.0105	CbGbCtD
Imipramine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00714	0.0101	CbGbCtD
Imipramine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00688	0.00968	CbGbCtD
Imipramine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00685	0.00964	CbGbCtD
Imipramine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00665	0.00936	CbGbCtD
Imipramine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00645	0.00909	CbGbCtD
Imipramine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00626	0.00882	CbGbCtD
Imipramine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00601	0.00847	CbGbCtD
Imipramine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00601	0.00847	CbGbCtD
Imipramine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00576	0.00812	CbGbCtD
Imipramine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00567	0.00798	CbGbCtD
Imipramine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00567	0.00798	CbGbCtD
Imipramine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00559	0.00787	CbGbCtD
Imipramine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00526	0.0074	CbGbCtD
Imipramine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00526	0.0074	CbGbCtD
Imipramine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00475	0.00669	CbGbCtD
Imipramine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00475	0.00669	CbGbCtD
Imipramine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00446	0.00628	CbGbCtD
Imipramine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0041	0.00578	CbGbCtD
Imipramine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00398	0.00561	CbGbCtD
Imipramine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0036	0.00507	CbGbCtD
Imipramine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0036	0.00507	CbGbCtD
Imipramine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00345	0.00486	CbGbCtD
Imipramine—ORM1—saliva—acquired immunodeficiency syndrome	0.00252	0.039	CbGeAlD
Imipramine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00135	0.0209	CbGeAlD
Imipramine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00109	0.0169	CbGeAlD
Imipramine—HTR7—nerve—acquired immunodeficiency syndrome	0.00105	0.0162	CbGeAlD
Imipramine—DRD2—nerve—acquired immunodeficiency syndrome	0.000993	0.0154	CbGeAlD
Imipramine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.000936	0.0145	CbGeAlD
Imipramine—HTR7—endothelium—acquired immunodeficiency syndrome	0.000894	0.0138	CbGeAlD
Imipramine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.000831	0.0129	CbGeAlD
Imipramine—KCND2—spinal cord—acquired immunodeficiency syndrome	0.000811	0.0125	CbGeAlD
Imipramine—HTR7—blood plasma—acquired immunodeficiency syndrome	0.000794	0.0123	CbGeAlD
Imipramine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000776	0.012	CbGeAlD
Imipramine—CHRM5—skin of body—acquired immunodeficiency syndrome	0.000717	0.0111	CbGeAlD
Imipramine—CYP2C18—digestive system—acquired immunodeficiency syndrome	0.000702	0.0109	CbGeAlD
Imipramine—KCND2—nervous system—acquired immunodeficiency syndrome	0.000684	0.0106	CbGeAlD
Imipramine—KCND2—central nervous system—acquired immunodeficiency syndrome	0.000658	0.0102	CbGeAlD
Imipramine—HTR2A—nerve—acquired immunodeficiency syndrome	0.000655	0.0101	CbGeAlD
Imipramine—KCND3—lung—acquired immunodeficiency syndrome	0.000644	0.00995	CbGeAlD
Imipramine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000634	0.0098	CbGeAlD
Imipramine—CYP2C18—vagina—acquired immunodeficiency syndrome	0.00062	0.00958	CbGeAlD
Imipramine—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000607	0.00939	CbGeAlD
Imipramine—KCND3—nervous system—acquired immunodeficiency syndrome	0.000596	0.00922	CbGeAlD
Imipramine—KCND3—central nervous system—acquired immunodeficiency syndrome	0.000574	0.00887	CbGeAlD
Imipramine—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00057	0.00881	CbGeAlD
Imipramine—CHRM4—nervous system—acquired immunodeficiency syndrome	0.000568	0.00878	CbGeAlD
Imipramine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000558	0.00862	CbGeAlD
Imipramine—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.000548	0.00847	CbGeAlD
Imipramine—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.000547	0.00845	CbGeAlD
Imipramine—KCND2—brain—acquired immunodeficiency syndrome	0.000523	0.00808	CbGeAlD
Imipramine—HTR6—nervous system—acquired immunodeficiency syndrome	0.000508	0.00786	CbGeAlD
Imipramine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000495	0.00766	CbGeAlD
Imipramine—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000489	0.00757	CbGeAlD
Imipramine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000459	0.00709	CbGeAlD
Imipramine—KCND3—brain—acquired immunodeficiency syndrome	0.000456	0.00705	CbGeAlD
Imipramine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000451	0.00698	CbGeAlD
Imipramine—CHRM5—nervous system—acquired immunodeficiency syndrome	0.000444	0.00686	CbGeAlD
Imipramine—KCND3—lymph node—acquired immunodeficiency syndrome	0.00044	0.00681	CbGeAlD
Imipramine—CHRM4—brain—acquired immunodeficiency syndrome	0.000434	0.00671	CbGeAlD
Imipramine—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.000427	0.00661	CbGeAlD
Imipramine—DRD2—retina—acquired immunodeficiency syndrome	0.000411	0.00636	CbGeAlD
Imipramine—SLC22A4—digestive system—acquired immunodeficiency syndrome	0.000406	0.00628	CbGeAlD
Imipramine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000406	0.00627	CbGeAlD
Imipramine—ORM1—blood—acquired immunodeficiency syndrome	0.000402	0.00622	CbGeAlD
Imipramine—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.000397	0.00613	CbGeAlD
Imipramine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.00039	0.00604	CbGeAlD
Imipramine—ORM1—bone marrow—acquired immunodeficiency syndrome	0.000389	0.00602	CbGeAlD
Imipramine—HTR6—brain—acquired immunodeficiency syndrome	0.000388	0.00601	CbGeAlD
Imipramine—ORM1—spinal cord—acquired immunodeficiency syndrome	0.000388	0.006	CbGeAlD
Imipramine—SLC22A4—blood—acquired immunodeficiency syndrome	0.000387	0.00599	CbGeAlD
Imipramine—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.000382	0.00591	CbGeAlD
Imipramine—SLC22A4—bone marrow—acquired immunodeficiency syndrome	0.000375	0.00579	CbGeAlD
Imipramine—SLC22A4—spinal cord—acquired immunodeficiency syndrome	0.000373	0.00577	CbGeAlD
Imipramine—SLC22A1—blood—acquired immunodeficiency syndrome	0.000369	0.0057	CbGeAlD
Imipramine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000361	0.00558	CbGeAlD
Imipramine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.00036	0.00557	CbGeAlD
Imipramine—SLC22A4—vagina—acquired immunodeficiency syndrome	0.000359	0.00555	CbGeAlD
Imipramine—ORM1—lung—acquired immunodeficiency syndrome	0.000353	0.00546	CbGeAlD
Imipramine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000349	0.00539	CbGeAlD
Imipramine—SLC6A4—blood—acquired immunodeficiency syndrome	0.000343	0.0053	CbGeAlD
Imipramine—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000342	0.00528	CbGeAlD
Imipramine—SLC22A4—lung—acquired immunodeficiency syndrome	0.000339	0.00525	CbGeAlD
Imipramine—CHRM5—brain—acquired immunodeficiency syndrome	0.000339	0.00525	CbGeAlD
Imipramine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.00033	0.00511	CbGeAlD
Imipramine—SLC6A3—lung—acquired immunodeficiency syndrome	0.000328	0.00507	CbGeAlD
Imipramine—ORM1—nervous system—acquired immunodeficiency syndrome	0.000327	0.00505	CbGeAlD
Imipramine—SLC22A3—vagina—acquired immunodeficiency syndrome	0.000327	0.00505	CbGeAlD
Imipramine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000325	0.00502	CbGeAlD
Imipramine—CHRM3—digestive system—acquired immunodeficiency syndrome	0.000321	0.00496	CbGeAlD
Imipramine—ORM1—central nervous system—acquired immunodeficiency syndrome	0.000315	0.00486	CbGeAlD
Imipramine—ADRA1B—brain—acquired immunodeficiency syndrome	0.00031	0.00479	CbGeAlD
Imipramine—SLC22A3—lung—acquired immunodeficiency syndrome	0.000309	0.00478	CbGeAlD
Imipramine—HTR7—digestive system—acquired immunodeficiency syndrome	0.000305	0.00472	CbGeAlD
Imipramine—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000305	0.00471	CbGeAlD
Imipramine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000304	0.0047	CbGeAlD
Imipramine—ADRA1D—brain—acquired immunodeficiency syndrome	0.000303	0.00469	CbGeAlD
Imipramine—SLC6A4—lung—acquired immunodeficiency syndrome	0.000301	0.00465	CbGeAlD
Imipramine—CHRM1—lung—acquired immunodeficiency syndrome	0.000299	0.00463	CbGeAlD
Imipramine—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000299	0.00463	CbGeAlD
Imipramine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000298	0.00461	CbGeAlD
Imipramine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000298	0.00461	CbGeAlD
Imipramine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000294	0.00454	CbGeAlD
Imipramine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000293	0.00454	CbGeAlD
Imipramine—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000293	0.00454	CbGeAlD
Imipramine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000292	0.00452	CbGeAlD
Imipramine—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000292	0.00451	CbGeAlD
Imipramine—HTR7—blood—acquired immunodeficiency syndrome	0.000291	0.0045	CbGeAlD
Imipramine—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000288	0.00446	CbGeAlD
Imipramine—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.000286	0.00442	CbGeAlD
Imipramine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000284	0.00439	CbGeAlD
Imipramine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000283	0.00437	CbGeAlD
Imipramine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000281	0.00434	CbGeAlD
Imipramine—HTR7—spinal cord—acquired immunodeficiency syndrome	0.00028	0.00434	CbGeAlD
Imipramine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000278	0.0043	CbGeAlD
Imipramine—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000277	0.00429	CbGeAlD
Imipramine—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.000275	0.00426	CbGeAlD
Imipramine—HTR2A—retina—acquired immunodeficiency syndrome	0.000271	0.00419	CbGeAlD
Imipramine—KCNH2—blood—acquired immunodeficiency syndrome	0.000271	0.00419	CbGeAlD
Imipramine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000268	0.00414	CbGeAlD
Imipramine—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.000267	0.00413	CbGeAlD
Imipramine—SLC6A2—lung—acquired immunodeficiency syndrome	0.000265	0.00409	CbGeAlD
Imipramine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000263	0.00407	CbGeAlD
Imipramine—KCNH2—bone marrow—acquired immunodeficiency syndrome	0.000262	0.00406	CbGeAlD
Imipramine—KCNH2—spinal cord—acquired immunodeficiency syndrome	0.000261	0.00404	CbGeAlD
Imipramine—HTR7—lung—acquired immunodeficiency syndrome	0.000255	0.00394	CbGeAlD
Imipramine—KCNH2—vagina—acquired immunodeficiency syndrome	0.000251	0.00389	CbGeAlD
Imipramine—CHRM3—nervous system—acquired immunodeficiency syndrome	0.000248	0.00384	CbGeAlD
Imipramine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000247	0.00382	CbGeAlD
Imipramine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000245	0.00379	CbGeAlD
Imipramine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000244	0.00377	CbGeAlD
Imipramine—ORM1—lymph node—acquired immunodeficiency syndrome	0.000241	0.00373	CbGeAlD
Imipramine—DRD2—lung—acquired immunodeficiency syndrome	0.000241	0.00373	CbGeAlD
Imipramine—SLC22A4—brain—acquired immunodeficiency syndrome	0.00024	0.00371	CbGeAlD
Imipramine—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.000239	0.00369	CbGeAlD
Imipramine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000238	0.00368	CbGeAlD
Imipramine—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000236	0.00366	CbGeAlD
Imipramine—HTR7—nervous system—acquired immunodeficiency syndrome	0.000236	0.00365	CbGeAlD
Imipramine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000236	0.00365	CbGeAlD
Imipramine—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000234	0.00361	CbGeAlD
Imipramine—CHRM2—brain—acquired immunodeficiency syndrome	0.000233	0.0036	CbGeAlD
Imipramine—SLC6A3—brain—acquired immunodeficiency syndrome	0.000232	0.00359	CbGeAlD
Imipramine—SLC22A4—lymph node—acquired immunodeficiency syndrome	0.000232	0.00359	CbGeAlD
Imipramine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000232	0.00359	CbGeAlD
Imipramine—SLC22A1—brain—acquired immunodeficiency syndrome	0.000229	0.00354	CbGeAlD
Imipramine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000228	0.00353	CbGeAlD
Imipramine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000228	0.00352	CbGeAlD
Imipramine—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000227	0.00352	CbGeAlD
Imipramine—HTR2C—brain—acquired immunodeficiency syndrome	0.000224	0.00347	CbGeAlD
Imipramine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000223	0.00345	CbGeAlD
Imipramine—CYP2B6—blood—acquired immunodeficiency syndrome	0.000222	0.00344	CbGeAlD
Imipramine—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000222	0.00343	CbGeAlD
Imipramine—KCNH2—nervous system—acquired immunodeficiency syndrome	0.00022	0.0034	CbGeAlD
Imipramine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000219	0.00339	CbGeAlD
Imipramine—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000219	0.00339	CbGeAlD
Imipramine—SLC22A3—brain—acquired immunodeficiency syndrome	0.000219	0.00338	CbGeAlD
Imipramine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000215	0.00333	CbGeAlD
Imipramine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000213	0.00329	CbGeAlD
Imipramine—CHRM1—brain—acquired immunodeficiency syndrome	0.000212	0.00328	CbGeAlD
Imipramine—KCNH2—central nervous system—acquired immunodeficiency syndrome	0.000212	0.00328	CbGeAlD
Imipramine—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.000211	0.00327	CbGeAlD
Imipramine—CYP2E1—blood—acquired immunodeficiency syndrome	0.000209	0.00323	CbGeAlD
Imipramine—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000206	0.00319	CbGeAlD
Imipramine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000203	0.00315	CbGeAlD
Imipramine—HRH1—vagina—acquired immunodeficiency syndrome	0.000201	0.00311	CbGeAlD
Imipramine—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000201	0.00311	CbGeAlD
Imipramine—CYP2B6—lung—acquired immunodeficiency syndrome	0.000195	0.00302	CbGeAlD
Imipramine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.00019	0.00295	CbGeAlD
Imipramine—HRH1—lung—acquired immunodeficiency syndrome	0.00019	0.00295	CbGeAlD
Imipramine—CHRM3—brain—acquired immunodeficiency syndrome	0.00019	0.00293	CbGeAlD
Imipramine—HTR1A—brain—acquired immunodeficiency syndrome	0.000189	0.00292	CbGeAlD
Imipramine—SLC6A2—brain—acquired immunodeficiency syndrome	0.000187	0.0029	CbGeAlD
Imipramine—CYP2E1—lung—acquired immunodeficiency syndrome	0.000183	0.00283	CbGeAlD
Imipramine—HTR2A—blood—acquired immunodeficiency syndrome	0.000181	0.00281	CbGeAlD
Imipramine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000181	0.0028	CbGeAlD
Imipramine—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000181	0.00279	CbGeAlD
Imipramine—HTR7—brain—acquired immunodeficiency syndrome	0.000181	0.00279	CbGeAlD
Imipramine—ABCB1—retina—acquired immunodeficiency syndrome	0.000178	0.00275	CbGeAlD
Imipramine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000176	0.00273	CbGeAlD
Imipramine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000176	0.00273	CbGeAlD
Imipramine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000175	0.0027	CbGeAlD
Imipramine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000174	0.00269	CbGeAlD
Imipramine—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000174	0.00269	CbGeAlD
Imipramine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000174	0.00268	CbGeAlD
Imipramine—DRD2—brain—acquired immunodeficiency syndrome	0.000171	0.00264	CbGeAlD
Imipramine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.00017	0.00263	CbGeAlD
Imipramine—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000169	0.00262	CbGeAlD
Imipramine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000168	0.0026	CbGeAlD
Imipramine—KCNH2—brain—acquired immunodeficiency syndrome	0.000168	0.0026	CbGeAlD
Imipramine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000168	0.0026	CbGeAlD
Imipramine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000165	0.00256	CbGeAlD
Imipramine—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000163	0.00252	CbGeAlD
Imipramine—KCNH2—lymph node—acquired immunodeficiency syndrome	0.000163	0.00251	CbGeAlD
Imipramine—HTR2A—lung—acquired immunodeficiency syndrome	0.000159	0.00246	CbGeAlD
Imipramine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.00077	CcSEcCtD
Imipramine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000147	0.00228	CbGeAlD
Imipramine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000769	CcSEcCtD
Imipramine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000769	CcSEcCtD
Imipramine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000768	CcSEcCtD
Imipramine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000765	CcSEcCtD
Imipramine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000765	CcSEcCtD
Imipramine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000146	0.000764	CcSEcCtD
Imipramine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000763	CcSEcCtD
Imipramine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000146	0.000763	CcSEcCtD
Imipramine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000146	0.000763	CcSEcCtD
Imipramine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000145	0.000759	CcSEcCtD
Imipramine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000145	0.000757	CcSEcCtD
Imipramine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000756	CcSEcCtD
Imipramine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000756	CcSEcCtD
Imipramine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000145	0.000756	CcSEcCtD
Imipramine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000144	0.000754	CcSEcCtD
Imipramine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000754	CcSEcCtD
Imipramine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000144	0.000753	CcSEcCtD
Imipramine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000752	CcSEcCtD
Imipramine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000752	CcSEcCtD
Imipramine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000751	CcSEcCtD
Imipramine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.00075	CcSEcCtD
Imipramine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.00075	CcSEcCtD
Imipramine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000749	CcSEcCtD
Imipramine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000748	CcSEcCtD
Imipramine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000143	0.000747	CcSEcCtD
Imipramine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000746	CcSEcCtD
Imipramine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000143	0.000746	CcSEcCtD
Imipramine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.000745	CcSEcCtD
Imipramine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000142	0.000744	CcSEcCtD
Imipramine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000142	0.000743	CcSEcCtD
Imipramine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000743	CcSEcCtD
Imipramine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000742	CcSEcCtD
Imipramine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000142	0.00219	CbGeAlD
Imipramine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000739	CcSEcCtD
Imipramine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000739	CcSEcCtD
Imipramine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000736	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000736	CcSEcCtD
Imipramine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000734	CcSEcCtD
Imipramine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00014	0.000733	CcSEcCtD
Imipramine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000733	CcSEcCtD
Imipramine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000732	CcSEcCtD
Imipramine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000732	CcSEcCtD
Imipramine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000727	CcSEcCtD
Imipramine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000726	CcSEcCtD
Imipramine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000139	0.000726	CcSEcCtD
Imipramine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000726	CcSEcCtD
Imipramine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000725	CcSEcCtD
Imipramine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000723	CcSEcCtD
Imipramine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000722	CcSEcCtD
Imipramine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000722	CcSEcCtD
Imipramine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000722	CcSEcCtD
Imipramine—CYP2B6—brain—acquired immunodeficiency syndrome	0.000138	0.00213	CbGeAlD
Imipramine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.000721	CcSEcCtD
Imipramine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000721	CcSEcCtD
Imipramine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000138	0.000719	CcSEcCtD
Imipramine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000138	0.000719	CcSEcCtD
Imipramine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000717	CcSEcCtD
Imipramine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000716	CcSEcCtD
Imipramine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000716	CcSEcCtD
Imipramine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.000714	CcSEcCtD
Imipramine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000136	0.00211	CbGeAlD
Imipramine—Oxcarbazepine—ALB—acquired immunodeficiency syndrome	0.000136	0.195	CrCbGaD
Imipramine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000711	CcSEcCtD
Imipramine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000711	CcSEcCtD
Imipramine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000136	0.000709	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000708	CcSEcCtD
Imipramine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000707	CcSEcCtD
Imipramine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000705	CcSEcCtD
Imipramine—HRH1—brain—acquired immunodeficiency syndrome	0.000135	0.00208	CbGeAlD
Imipramine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000703	CcSEcCtD
Imipramine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000134	0.00208	CbGeAlD
Imipramine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000134	0.0007	CcSEcCtD
Imipramine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000699	CcSEcCtD
Imipramine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000698	CcSEcCtD
Imipramine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000698	CcSEcCtD
Imipramine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000133	0.000697	CcSEcCtD
Imipramine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000697	CcSEcCtD
Imipramine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000696	CcSEcCtD
Imipramine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000133	0.000695	CcSEcCtD
Imipramine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000133	0.000695	CcSEcCtD
Imipramine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000695	CcSEcCtD
Imipramine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000693	CcSEcCtD
Imipramine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000693	CcSEcCtD
Imipramine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000693	CcSEcCtD
Imipramine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000132	0.000692	CcSEcCtD
Imipramine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000692	CcSEcCtD
Imipramine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.00069	CcSEcCtD
Imipramine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.00069	CcSEcCtD
Imipramine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.00069	CcSEcCtD
Imipramine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000687	CcSEcCtD
Imipramine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000687	CcSEcCtD
Imipramine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.000687	CcSEcCtD
Imipramine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000131	0.00203	CbGeAlD
Imipramine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.000686	CcSEcCtD
Imipramine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000131	0.000685	CcSEcCtD
Imipramine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000684	CcSEcCtD
Imipramine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000683	CcSEcCtD
Imipramine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.000682	CcSEcCtD
Imipramine—HRH1—lymph node—acquired immunodeficiency syndrome	0.00013	0.00201	CbGeAlD
Imipramine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000679	CcSEcCtD
Imipramine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000678	CcSEcCtD
Imipramine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000677	CcSEcCtD
Imipramine—CYP2E1—brain—acquired immunodeficiency syndrome	0.00013	0.002	CbGeAlD
Imipramine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000676	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000676	CcSEcCtD
Imipramine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000129	0.002	CbGeAlD
Imipramine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000675	CcSEcCtD
Imipramine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000673	CcSEcCtD
Imipramine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000672	CcSEcCtD
Imipramine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000672	CcSEcCtD
Imipramine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000672	CcSEcCtD
Imipramine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000671	CcSEcCtD
Imipramine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000128	0.000671	CcSEcCtD
Imipramine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.00067	CcSEcCtD
Imipramine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000128	0.000669	CcSEcCtD
Imipramine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000668	CcSEcCtD
Imipramine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000666	CcSEcCtD
Imipramine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.000665	CcSEcCtD
Imipramine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.000664	CcSEcCtD
Imipramine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000664	CcSEcCtD
Imipramine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000663	CcSEcCtD
Imipramine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000127	0.000663	CcSEcCtD
Imipramine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000662	CcSEcCtD
Imipramine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000127	0.000662	CcSEcCtD
Imipramine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000662	CcSEcCtD
Imipramine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000661	CcSEcCtD
Imipramine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000126	0.000661	CcSEcCtD
Imipramine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000126	0.00195	CbGeAlD
Imipramine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000126	0.000659	CcSEcCtD
Imipramine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000126	0.000659	CcSEcCtD
Imipramine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000658	CcSEcCtD
Imipramine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000657	CcSEcCtD
Imipramine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.000657	CcSEcCtD
Imipramine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000125	0.000656	CcSEcCtD
Imipramine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000125	0.000653	CcSEcCtD
Imipramine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000125	0.000653	CcSEcCtD
Imipramine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000652	CcSEcCtD
Imipramine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000652	CcSEcCtD
Imipramine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000125	0.00193	CbGeAlD
Imipramine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000652	CcSEcCtD
Imipramine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000124	0.000649	CcSEcCtD
Imipramine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000648	CcSEcCtD
Imipramine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000124	0.000647	CcSEcCtD
Imipramine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.000647	CcSEcCtD
Imipramine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000643	CcSEcCtD
Imipramine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000642	CcSEcCtD
Imipramine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.00064	CcSEcCtD
Imipramine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000639	CcSEcCtD
Imipramine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000638	CcSEcCtD
Imipramine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000638	CcSEcCtD
Imipramine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000635	CcSEcCtD
Imipramine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000635	CcSEcCtD
Imipramine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000634	CcSEcCtD
Imipramine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000633	CcSEcCtD
Imipramine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000632	CcSEcCtD
Imipramine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000631	CcSEcCtD
Imipramine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000628	CcSEcCtD
Imipramine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00012	0.000626	CcSEcCtD
Imipramine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000625	CcSEcCtD
Imipramine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000625	CcSEcCtD
Imipramine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00012	0.000625	CcSEcCtD
Imipramine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000622	CcSEcCtD
Imipramine—ABCB1—blood—acquired immunodeficiency syndrome	0.000119	0.00184	CbGeAlD
Imipramine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000619	CcSEcCtD
Imipramine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000618	CcSEcCtD
Imipramine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000118	0.000615	CcSEcCtD
Imipramine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000614	CcSEcCtD
Imipramine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000613	CcSEcCtD
Imipramine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000613	CcSEcCtD
Imipramine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.00061	CcSEcCtD
Imipramine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000117	0.00061	CcSEcCtD
Imipramine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000608	CcSEcCtD
Imipramine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000608	CcSEcCtD
Imipramine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000607	CcSEcCtD
Imipramine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000607	CcSEcCtD
Imipramine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000604	CcSEcCtD
Imipramine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000602	CcSEcCtD
Imipramine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000601	CcSEcCtD
Imipramine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000115	0.00178	CbGeAlD
Imipramine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000115	0.00177	CbGeAlD
Imipramine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000594	CcSEcCtD
Imipramine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.00059	CcSEcCtD
Imipramine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.00059	CcSEcCtD
Imipramine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.00059	CcSEcCtD
Imipramine—HTR2A—brain—acquired immunodeficiency syndrome	0.000113	0.00174	CbGeAlD
Imipramine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000586	CcSEcCtD
Imipramine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000586	CcSEcCtD
Imipramine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000585	CcSEcCtD
Imipramine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000582	CcSEcCtD
Imipramine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.000581	CcSEcCtD
Imipramine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000581	CcSEcCtD
Imipramine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.00058	CcSEcCtD
Imipramine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000576	CcSEcCtD
Imipramine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000576	CcSEcCtD
Imipramine—ABCB1—vagina—acquired immunodeficiency syndrome	0.00011	0.0017	CbGeAlD
Imipramine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000576	CcSEcCtD
Imipramine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000574	CcSEcCtD
Imipramine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000573	CcSEcCtD
Imipramine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000568	CcSEcCtD
Imipramine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000567	CcSEcCtD
Imipramine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000564	CcSEcCtD
Imipramine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000564	CcSEcCtD
Imipramine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000563	CcSEcCtD
Imipramine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000562	CcSEcCtD
Imipramine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000562	CcSEcCtD
Imipramine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000562	CcSEcCtD
Imipramine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000562	CcSEcCtD
Imipramine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000559	CcSEcCtD
Imipramine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000558	CcSEcCtD
Imipramine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000551	CcSEcCtD
Imipramine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000549	CcSEcCtD
Imipramine—ABCB1—lung—acquired immunodeficiency syndrome	0.000104	0.00161	CbGeAlD
Imipramine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000544	CcSEcCtD
Imipramine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000543	CcSEcCtD
Imipramine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.000543	CcSEcCtD
Imipramine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000541	CcSEcCtD
Imipramine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000541	CcSEcCtD
Imipramine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000103	0.00054	CcSEcCtD
Imipramine—Acepromazine—ALB—acquired immunodeficiency syndrome	0.000103	0.147	CrCbGaD
Imipramine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000538	CcSEcCtD
Imipramine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000103	0.00159	CbGeAlD
Imipramine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000536	CcSEcCtD
Imipramine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000535	CcSEcCtD
Imipramine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000533	CcSEcCtD
Imipramine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000532	CcSEcCtD
Imipramine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000531	CcSEcCtD
Imipramine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000526	CcSEcCtD
Imipramine—Thioproperazine—ALB—acquired immunodeficiency syndrome	0.000101	0.144	CrCbGaD
Imipramine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	9.92e-05	0.000518	CcSEcCtD
Imipramine—Pipotiazine—ALB—acquired immunodeficiency syndrome	9.89e-05	0.141	CrCbGaD
Imipramine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	9.87e-05	0.000516	CcSEcCtD
Imipramine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	9.87e-05	0.000516	CcSEcCtD
Imipramine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	9.77e-05	0.000511	CcSEcCtD
Imipramine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	9.75e-05	0.00051	CcSEcCtD
Imipramine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	9.72e-05	0.000508	CcSEcCtD
Imipramine—Rash—Efavirenz—acquired immunodeficiency syndrome	9.69e-05	0.000506	CcSEcCtD
Imipramine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	9.68e-05	0.000506	CcSEcCtD
Imipramine—Nausea—Indinavir—acquired immunodeficiency syndrome	9.66e-05	0.000505	CcSEcCtD
Imipramine—ABCB1—nervous system—acquired immunodeficiency syndrome	9.65e-05	0.00149	CbGeAlD
Imipramine—Headache—Efavirenz—acquired immunodeficiency syndrome	9.63e-05	0.000503	CcSEcCtD
Imipramine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	9.62e-05	0.000503	CcSEcCtD
Imipramine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	9.39e-05	0.000491	CcSEcCtD
Imipramine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	9.35e-05	0.000489	CcSEcCtD
Imipramine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	9.3e-05	0.000486	CcSEcCtD
Imipramine—ABCB1—central nervous system—acquired immunodeficiency syndrome	9.29e-05	0.00144	CbGeAlD
Imipramine—Rash—Delavirdine—acquired immunodeficiency syndrome	9.27e-05	0.000484	CcSEcCtD
Imipramine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.26e-05	0.000484	CcSEcCtD
Imipramine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	9.26e-05	0.000484	CcSEcCtD
Imipramine—Headache—Delavirdine—acquired immunodeficiency syndrome	9.21e-05	0.000481	CcSEcCtD
Imipramine—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.13e-05	0.000477	CcSEcCtD
Imipramine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	8.99e-05	0.00047	CcSEcCtD
Imipramine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	8.96e-05	0.000468	CcSEcCtD
Imipramine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.95e-05	0.000468	CcSEcCtD
Imipramine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	8.83e-05	0.000462	CcSEcCtD
Imipramine—Nausea—Delavirdine—acquired immunodeficiency syndrome	8.73e-05	0.000456	CcSEcCtD
Imipramine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	8.65e-05	0.000452	CcSEcCtD
Imipramine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	8.64e-05	0.000452	CcSEcCtD
Imipramine—Rash—Ritonavir—acquired immunodeficiency syndrome	8.57e-05	0.000448	CcSEcCtD
Imipramine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	8.56e-05	0.000448	CcSEcCtD
Imipramine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	8.54e-05	0.000446	CcSEcCtD
Imipramine—Headache—Ritonavir—acquired immunodeficiency syndrome	8.52e-05	0.000445	CcSEcCtD
Imipramine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.32e-05	0.000435	CcSEcCtD
Imipramine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.25e-05	0.000431	CcSEcCtD
Imipramine—Rash—Saquinavir—acquired immunodeficiency syndrome	8.25e-05	0.000431	CcSEcCtD
Imipramine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.24e-05	0.000431	CcSEcCtD
Imipramine—Headache—Saquinavir—acquired immunodeficiency syndrome	8.2e-05	0.000428	CcSEcCtD
Imipramine—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.08e-05	0.000422	CcSEcCtD
Imipramine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	7.94e-05	0.000415	CcSEcCtD
Imipramine—Rash—Lamivudine—acquired immunodeficiency syndrome	7.87e-05	0.000411	CcSEcCtD
Imipramine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	7.86e-05	0.000411	CcSEcCtD
Imipramine—Clomipramine—ALB—acquired immunodeficiency syndrome	7.82e-05	0.112	CrCbGaD
Imipramine—Headache—Lamivudine—acquired immunodeficiency syndrome	7.82e-05	0.000409	CcSEcCtD
Imipramine—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.77e-05	0.000406	CcSEcCtD
Imipramine—Nortriptyline—ALB—acquired immunodeficiency syndrome	7.64e-05	0.109	CrCbGaD
Imipramine—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.41e-05	0.000388	CcSEcCtD
Imipramine—ABCB1—brain—acquired immunodeficiency syndrome	7.38e-05	0.00114	CbGeAlD
Imipramine—ABCB1—lymph node—acquired immunodeficiency syndrome	7.13e-05	0.0011	CbGeAlD
Imipramine—Chlorpromazine—ALB—acquired immunodeficiency syndrome	5.36e-05	0.0767	CrCbGaD
Imipramine—Amitriptyline—ALB—acquired immunodeficiency syndrome	5.3e-05	0.0758	CrCbGaD
Imipramine—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.28e-05	0.000386	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.27e-05	0.000384	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.27e-05	0.000383	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.26e-05	0.000382	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.26e-05	0.000382	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.26e-05	0.000381	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.26e-05	0.00038	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.25e-05	0.000378	CbGpPWpGaD
Imipramine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.25e-05	0.000378	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.23e-05	0.000373	CbGpPWpGaD
Imipramine—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.23e-05	0.000372	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.22e-05	0.00037	CbGpPWpGaD
Imipramine—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.22e-05	0.00037	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.21e-05	0.000368	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.21e-05	0.000367	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.21e-05	0.000367	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.21e-05	0.000366	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.21e-05	0.000366	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.21e-05	0.000366	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.21e-05	0.000366	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.21e-05	0.000365	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.21e-05	0.000365	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.2e-05	0.000364	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.2e-05	0.000362	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.2e-05	0.000362	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.19e-05	0.000361	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.19e-05	0.00036	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.19e-05	0.00036	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.19e-05	0.000359	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.19e-05	0.000359	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.17e-05	0.000355	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.17e-05	0.000354	CbGpPWpGaD
Imipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.17e-05	0.000352	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.16e-05	0.000352	CbGpPWpGaD
Imipramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.16e-05	0.000352	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.16e-05	0.000351	CbGpPWpGaD
Imipramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.16e-05	0.000351	CbGpPWpGaD
Imipramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.16e-05	0.000349	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.15e-05	0.000348	CbGpPWpGaD
Imipramine—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.15e-05	0.000346	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.14e-05	0.000346	CbGpPWpGaD
Imipramine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.14e-05	0.000345	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.14e-05	0.000344	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.14e-05	0.000344	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.12e-05	0.000339	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.000336	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.11e-05	0.000336	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.11e-05	0.000336	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.1e-05	0.000334	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.1e-05	0.000333	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.1e-05	0.000333	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.1e-05	0.000332	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.09e-05	0.000331	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.09e-05	0.000331	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.09e-05	0.000331	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.09e-05	0.00033	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.09e-05	0.000329	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.09e-05	0.000328	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.08e-05	0.000328	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.08e-05	0.000328	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.08e-05	0.000327	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.08e-05	0.000327	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.08e-05	0.000326	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.08e-05	0.000326	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.07e-05	0.000325	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.07e-05	0.000324	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.07e-05	0.000322	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.06e-05	0.000322	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.05e-05	0.000319	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.05e-05	0.000317	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.02e-05	0.000309	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.02e-05	0.000308	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.02e-05	0.000308	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.01e-05	0.000305	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.01e-05	0.000304	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1e-05	0.000304	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1e-05	0.000304	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1e-05	0.000303	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1e-05	0.000303	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1e-05	0.000303	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	9.99e-06	0.000302	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.98e-06	0.000302	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.93e-06	0.0003	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.91e-06	0.0003	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.91e-06	0.0003	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.91e-06	0.0003	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.88e-06	0.000299	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.88e-06	0.000299	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.87e-06	0.000299	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.87e-06	0.000298	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.85e-06	0.000298	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.85e-06	0.000298	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.85e-06	0.000298	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.84e-06	0.000298	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.75e-06	0.000295	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.72e-06	0.000294	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.6e-06	0.00029	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.46e-06	0.000286	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	9.45e-06	0.000286	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.43e-06	0.000285	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.43e-06	0.000285	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.32e-06	0.000282	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.25e-06	0.00028	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.2e-06	0.000278	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—ALB—acquired immunodeficiency syndrome	9.18e-06	0.000278	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.17e-06	0.000277	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.16e-06	0.000277	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.1e-06	0.000275	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.08e-06	0.000275	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.06e-06	0.000274	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.05e-06	0.000274	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.02e-06	0.000273	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.97e-06	0.000271	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.96e-06	0.000271	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.94e-06	0.00027	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.92e-06	0.00027	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.91e-06	0.00027	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.7e-06	0.000263	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.7e-06	0.000263	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—ALB—acquired immunodeficiency syndrome	8.67e-06	0.000262	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.65e-06	0.000262	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.65e-06	0.000262	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.56e-06	0.000259	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.56e-06	0.000259	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.54e-06	0.000258	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.54e-06	0.000258	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.52e-06	0.000258	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.51e-06	0.000257	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.51e-06	0.000257	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.48e-06	0.000257	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.48e-06	0.000257	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.46e-06	0.000256	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.4e-06	0.000254	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.4e-06	0.000254	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.39e-06	0.000254	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.38e-06	0.000253	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.38e-06	0.000253	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.28e-06	0.000251	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.1e-06	0.000245	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.79e-06	0.000236	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.62e-06	0.00023	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.54e-06	0.000228	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.5e-06	0.000227	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.42e-06	0.000225	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.38e-06	0.000223	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.31e-06	0.000221	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.27e-06	0.00022	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.23e-06	0.000219	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.18e-06	0.000217	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.07e-06	0.000214	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.96e-06	0.000211	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.79e-06	0.000205	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.75e-06	0.000204	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.71e-06	0.000203	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.64e-06	0.000201	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.62e-06	0.0002	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.61e-06	0.0002	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.52e-06	0.000197	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.51e-06	0.000197	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.5e-06	0.000197	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.48e-06	0.000196	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.47e-06	0.000196	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.45e-06	0.000195	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.42e-06	0.000194	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.41e-06	0.000194	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.4e-06	0.000194	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.39e-06	0.000193	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.38e-06	0.000193	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.37e-06	0.000193	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.36e-06	0.000192	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.32e-06	0.000191	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.32e-06	0.000191	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.3e-06	0.000191	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.3e-06	0.00019	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.28e-06	0.00019	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.28e-06	0.00019	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.26e-06	0.000189	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.2e-06	0.000188	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.19e-06	0.000187	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.96e-06	0.00018	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.86e-06	0.000177	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.85e-06	0.000177	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.83e-06	0.000176	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.83e-06	0.000176	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.81e-06	0.000176	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	5.76e-06	0.000174	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.76e-06	0.000174	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.76e-06	0.000174	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.74e-06	0.000174	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.74e-06	0.000174	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.72e-06	0.000173	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.71e-06	0.000173	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.69e-06	0.000172	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	5.64e-06	0.00017	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.63e-06	0.00017	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.62e-06	0.00017	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	5.36e-06	0.000162	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.3e-06	0.00016	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.29e-06	0.00016	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.27e-06	0.000159	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.27e-06	0.000159	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5e-06	0.000151	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.97e-06	0.00015	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	4.96e-06	0.00015	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.79e-06	0.000145	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.76e-06	0.000144	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.5e-06	0.000136	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.48e-06	0.000135	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—ALB—acquired immunodeficiency syndrome	4.26e-06	0.000129	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	4.18e-06	0.000126	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.92e-06	0.000119	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.9e-06	0.000118	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.9e-06	0.000118	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.88e-06	0.000117	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.74e-06	0.000113	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.72e-06	0.000112	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.44e-06	0.000104	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.43e-06	0.000104	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.39e-06	0.000103	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.38e-06	0.000102	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.37e-06	0.000102	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.37e-06	0.000102	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.36e-06	0.000102	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.36e-06	0.000102	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.35e-06	0.000101	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.34e-06	0.000101	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.33e-06	0.000101	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.32e-06	0.0001	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.31e-06	0.0001	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.3e-06	9.99e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	3.22e-06	9.74e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.14e-06	9.51e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.11e-06	9.42e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.11e-06	9.41e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	2.96e-06	8.96e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.94e-06	8.89e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.81e-06	8.51e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.65e-06	8e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	2.51e-06	7.59e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.31e-06	6.97e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.29e-06	6.94e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.2e-06	6.64e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.02e-06	6.12e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.99e-06	6.03e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.99e-06	6.01e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.98e-06	5.99e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.97e-06	5.97e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.96e-06	5.92e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.95e-06	5.9e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.94e-06	5.86e-05	CbGpPWpGaD
